The PANA project will be the main project of European research on Alzheimer's disease, and will be coordinated from the University Hospital of Santiago. This project aims to develop nanostructures that allow early diagnosis of Alzheimer's disease five years before the start of the clinical symptoms.
The PANA European project (Promoting Active Ageing: nanodevices for Alzheimer's Disease at ultra-early stages) arises in order to help mitigate and delay the devastating effects of this disease. This is the first H2020 project coordinated by Tomas Sobrino, researcher of the Galician Health Service and technical director of the Laboratory for Research in Clinical Neuroscience Institute of Health Research of Santiago de Compostela (IDIS), together with Jose Castillo, chief of Neurology and scientific director of IDIS.
The PANA project aims to develop an early warning system based on nanotechnology, by designing multimodal nanostructures that bind to a specific biomarker of disease that can be detected by techniques such as magnetic resonance and positron emission Tomography (PET). "This will mean a revolution in the early diagnosis of Alzheimer's disease and further treatment in the early stages of the disease," said Tomas Sobrino.
The project will be developed over five years and is endowed with a budget of 7.8 million euros managed from Santiago, involving more than 100 European researchers, led by the Group of Clinical Neurosciences IDIS.
Full article (Spanish): click here.